Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Global Public Health
|
November 15, 2016
The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam
Hazel V J Moir, Brigitte Tenni, Deborah Gleeson, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
November 9, 2017
Financial costs associated with monopolies on biologic medicines in Australia
Deborah Gleeson, Belinda Townsend, Ruth Lopert, et al.
Globalization and Health
|
October 26, 2018
Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States
Kyung-Bok Son, Ruth Lopert, Deborah Gleeson, et al.
Lancet (London, England)
|
June 28, 2002
Differential pricing of drugs: a role for cost-effectiveness analysis?
Ruth Lopert, Danielle L Lang, Suzanne R Hill, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
January 8, 2013
Medication information for patients with limited English proficiency: lessons from the European Union
Marsha Regenstein, Ellie Andres, Dylan Nelson, et al.
Health Services Research
|
March 19, 2011
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
Bruce Stuart, Amy Davidoff, Ruth Lopert, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 16, 2012
Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes
Amy Davidoff, Ruth Lopert, Bruce Stuart, et al.
BMJ (Clinical Research Ed.)
|
November 11, 2025
Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements
Tarang Sharma, Krista Kruja, Christine Årdal, et al.
Internal Medicine Journal
|
October 19, 2021
A sorry tale of unnecessary secrecy about medicine safety
Barbara Mintzes, Alice Bhasale, Marc Torka, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 17, 2014
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
László Gulácsi, Fanni Rencz, Márta Péntek, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Global Public Health
|
November 15, 2016
The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam
Hazel V J Moir, Brigitte Tenni, Deborah Gleeson, et al.
Australian Health Review : a Publication of the Australian Hospital Association
|
November 9, 2017
Financial costs associated with monopolies on biologic medicines in Australia
Deborah Gleeson, Belinda Townsend, Ruth Lopert, et al.
Globalization and Health
|
October 26, 2018
Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States
Kyung-Bok Son, Ruth Lopert, Deborah Gleeson, et al.
Lancet (London, England)
|
June 28, 2002
Differential pricing of drugs: a role for cost-effectiveness analysis?
Ruth Lopert, Danielle L Lang, Suzanne R Hill, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
January 8, 2013
Medication information for patients with limited English proficiency: lessons from the European Union
Marsha Regenstein, Ellie Andres, Dylan Nelson, et al.
Health Services Research
|
March 19, 2011
Does medication adherence lower Medicare spending among beneficiaries with diabetes?
Bruce Stuart, Amy Davidoff, Ruth Lopert, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 16, 2012
Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes
Amy Davidoff, Ruth Lopert, Bruce Stuart, et al.
BMJ (Clinical Research Ed.)
|
November 11, 2025
Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements
Tarang Sharma, Krista Kruja, Christine Årdal, et al.
Internal Medicine Journal
|
October 19, 2021
A sorry tale of unnecessary secrecy about medicine safety
Barbara Mintzes, Alice Bhasale, Marc Torka, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 17, 2014
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
László Gulácsi, Fanni Rencz, Márta Péntek, et al.
Page
of 5